Foreign investment bill targeting China
heads for Senate panel vote
Send a link to a friend
[May 12, 2018]
By Diane Bartz
WASHINGTON (Reuters) - A bill aimed at
tightening oversight of foreign investment in the United States because
of concern about China's acquisition of critical technology is headed
for a vote this month in the U.S. Senate Banking Committee, the panel
said on Friday.
The committee also released draft proposals that will be voted on to
amend the bill, which was introduced last November by Senator John
Cornyn.
Proposed changes to the measure appear aimed largely at blunting
opposition from high tech companies and investment firms, which had
worried that even innocuous transactions would be subject to extended
reviews by the Committee on Foreign Investment in the United States, or
CFIUS.
CFIUS is an inter-agency panel led by the Treasury Department that
assesses potential foreign investment to ensure it does not harm
national security.

The bill in the Senate, and a companion measure in the U.S. House of
Representatives, would broaden CFIUS' reach in hopes of reining in
China's acquisition of U.S. high tech knowledge even as China has sought
to focus on production of higher-value goods, like robots, computers and
telecommunications equipment.
The bipartisan legislation has the support of President Donald Trump's
administration.
The new version eliminates a measure which some tech companies
complained would force them to go to CFIUS to get approval for
technology sales if they involved intellectual property licensing and
support.
[to top of second column]
|

The U.S. Capitol building is seen at sunset in Washington, U.S. May
17, 2017. REUTERS/Zach Gibson

The draft also spells out that an investment can be deemed passive,
and not subject to CFIUS oversight, if foreign investors have no
access to non-public technical information or rights to be on the
board of directors of a U.S. critical infrastructure company.
The proposed changes include noting specifically that CFIUS could
consider in its national security review if a deal would potentially
expose sensitive data about U.S. citizens, including genetic
information.
Cornyn supports the proposed changes.
"As China has increasingly weaponized investment, it's a national
security imperative to strengthen the interagency review process to
safeguard military and dual-use technology and know-how," he said in
a statement that accompanied the release of the proposed changes.
The panel has killed a long list of deals, including a plan for
Chinese conglomerate HNA Group to buy most of SkyBridge Capital, a
hedge fund investment firm founded by Trump's former aide Anthony
Scaramucci.
(Reporting by Diane Bartz; Editing by Tom Brown)
[© 2018 Thomson Reuters. All rights
reserved.]
Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |